3 Minute read
Concussion, or mild traumatic brain injury (mTBI) affects millions world-wide each year due to motor accidents, falls, assaults, domestic violence, contact sports and war. It is now appreciated that a history of concussion increases the risk of developing long-term emotional and neurocognitive disorders. These include anxiety and depression, as well as neurodegenerative conditions such as Alzheimer’s. Critically, we do not know the mechanisms behind long-term negative effects of mTBI on brain health.
Over the last decade there is a growing literature emerging on how glial cells (microglia and astrocytes) and neuronal populations interact to control normal function and to understand how neuroinflammatory changes may be involved in the progression of a range of neuropsy chiatric and neurodegenerative disorders, a number of which are characterised by cognitive deficits.
In normal brain cognition is highly dependent on a balance between excitation (firing of pyramidal glutamatergic neurons) and inhibition (synchronisation of firing by parvalbumin containing GABAergic interneurons (PVI)). Gamma band oscillations, generated by these PVIs are crucial for maintenance of normal cognition. These interneurons are fast spiking, fast firing, have a high energy demand and as such are particularly susceptible to changes in neuroinflammation and oxidative stress. These interactions in different brains regions of relevance to cognition (e.g. prefrontal cortex & dorsal hippocampus) are now under intense scrutiny as changes in inflammation appear to be key drivers of brain injury, mood disorders and neurodegenerative disease. Understanding these interactions and their relationship over time in validated preclinical models related to TBI will aid in the identification and testing of novel therapeutic (both pharmacological and non-pharmacological (e.g. exercise)) interventions.
In the current project, we will investigate the immune cell response to mTBI in a clinically relevant mouse model. Our overall aims are to:
- Assess the influence mTBI on brain resident immune cells (microglia/astrocyte density and activation), brain tissue inflammation (multiplex cytokine array analysis) and neuronal populations (parvalbumin GABAergic interneurons and associated perineuronal nets)
- Utilise transgenic models and cell-depletion strategies in the mild TBI model. (Complimentary studies will be conducted in the moderate TBI model in Melbourne).
- Target immune and neuronal cell subtypes and functions in the brain to prevent / reverse neuronal and behavioural deficits in mice after mTBI.
The University of Melbourne:
The University of Manchester:
*Click on the researcher's name above to learn more about their publication and grant successes.
The successful candidate will be based at University of Manchester with a minimum twelve-month stay at the University of Melbourne.
Applications for this project will close once a suitable candidate is identified.
To view the entry requirements please visit How to apply. Intending applicants should contact Dr Juliet Taylor with a 1-2 page cover letter outlining your expression of interest, a recent writing sample, academic transcripts, and Curriculum Vitae.
First published on 13 December 2022.
Share this article
How to apply
Once you’ve identified a joint PhD project that you’re interested in, you can apply to the Melbourne Manchester Graduate Research Group.
See the research projects that are currently being undertaken by Melbourne and Manchester Graduate Research Group members.
Correlating brain and systemic inflammation with peripheral and central neurodegeneration in mice and humans
One fully funded project using an experimental model of stroke to longitudinally measure inflammatory markers and immune cell activation in the brain, blood and eye at acute and long-term timepoints after stroke is available.
Find a supervisor or research project
Discover how to find a supervisor and learn how they can support your graduate research, or search available research projects.